Dr. Erik Cabrera, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $147,672 | 54 | 75.1% |
| Consulting Fee | $23,473 | 5 | 11.9% |
| Travel and Lodging | $19,273 | 80 | 9.8% |
| Food and Beverage | $6,071 | 101 | 3.1% |
| Education | $29.99 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $166,845 | 184 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $23,461 | 35 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $5,920 | 12 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $121.84 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $55.84 | 3 | $0 (2023) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $37.96 | 2 | $0 (2024) |
| Allergan Inc. | $29.99 | 1 | $0 (2018) |
| Alkermes, Inc. | $17.78 | 1 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $15.48 | 1 | $0 (2022) |
| Amarin Pharma Inc. | $13.76 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $119,736 | 153 | Neurocrine Biosciences, Inc. ($90,516) |
| 2023 | $76,292 | 76 | Neurocrine Biosciences, Inc. ($76,011) |
| 2022 | $258.45 | 7 | Neurocrine Biosciences, Inc. ($217.25) |
| 2019 | $84.58 | 2 | Otsuka America Pharmaceutical, Inc. ($70.82) |
| 2018 | $148.09 | 3 | Neurocrine Biosciences, Inc. ($100.32) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $123.04 | General |
| Category: Neuropsychiatry | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $50.00 | General |
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,563.00 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $499.12 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $212.96 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $190.12 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $117.46 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $67.86 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $50.00 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $25.18 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Neuropsychiatry | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,742.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $144.51 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,563.00 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $980.12 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $473.95 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $437.03 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $50.00 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 2,128 | 3,314 | $603,960 | $297,720 |
| 2022 | 8 | 2,172 | 3,308 | $620,846 | $250,268 |
| 2021 | 7 | 1,671 | 2,729 | $641,239 | $253,339 |
| 2020 | 9 | 1,602 | 2,432 | $570,700 | $223,787 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 883 | 1,878 | $319,260 | $163,340 | 51.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 600 | 602 | $144,480 | $66,973 | 46.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 438 | 616 | $80,080 | $37,404 | 46.7% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 113 | 124 | $31,000 | $15,881 | 51.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 94 | 94 | $29,140 | $14,121 | 48.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 726 | 1,462 | $257,936 | $99,442 | 38.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 528 | 528 | $126,720 | $56,655 | 44.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 464 | 771 | $100,230 | $44,642 | 44.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 160 | 160 | $48,768 | $19,747 | 40.5% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 136 | 154 | $39,004 | $16,407 | 42.1% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 92 | 166 | $35,195 | $9,255 | 26.3% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 53 | 54 | $9,288 | $2,729 | 29.4% |
| 99326 | New patient custodial care facility, group care, or assisted living visit, typically 45 minutes | Office | 2022 | 13 | 13 | $3,705 | $1,390 | 37.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 634 | 1,433 | $295,198 | $105,494 | 35.7% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 685 | 704 | $212,608 | $98,496 | 46.3% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2021 | 114 | 327 | $69,331 | $24,244 | 35.0% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 144 | 167 | $43,253 | $19,211 | 44.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 60 | 64 | $11,584 | $2,790 | 24.1% |
| 99326 | New patient assisted living visit, typically 45 minutes | Office | 2021 | 17 | 17 | $4,845 | $1,769 | 36.5% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 17 | 17 | $4,420 | $1,334 | 30.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 506 | 1,161 | $239,166 | $84,283 | 35.2% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 549 | 560 | $169,120 | $76,514 | 45.2% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2020 | 117 | 238 | $61,166 | $23,566 | 38.5% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 80 | 96 | $24,864 | $11,089 | 44.6% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 87 | 91 | $18,746 | $7,102 | 37.9% |
About Dr. Erik Cabrera, M.D
Dr. Erik Cabrera, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1003200395.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erik Cabrera, M.D has received a total of $196,519 in payments from pharmaceutical and medical device companies, with $119,736 received in 2024. These payments were reported across 241 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($147,672).
As a Medicare-enrolled provider, Cabrera has provided services to 7,573 Medicare beneficiaries, totaling 11,783 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Psychiatry
- Location Miami, FL
- Active Since 03/24/2015
- Last Updated 08/08/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003200395
Products in Payments
- INGREZZA (Drug) $166,825
- REXULTI (Drug) $23,374
- NUEDEXTA (Drug) $124.99
- NUPLAZID (Drug) $121.84
- AUSTEDO (Drug) $55.84
- VRAYLAR (Drug) $29.99
- Ongentys (Drug) $20.33
- Aristada 441 mg (Drug) $17.78
- COBENFY (Drug) $16.11
- Nuedexta (Drug) $15.48
- Vascepa (Drug) $13.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Miami
Dr. Stephen George, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $265,815
Corneliu Luca, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $261,021
Dr. Andrew Niekamp, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $249,022
Dr. Hadar Lev-Tov, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $238,778
Dr. Scott Sandilands, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $218,068
Dr. Michael Baraga
Student in an Organized Health Care Education/Training Program — Payments: $148,781